Susquehanna International Group, LLP Anixa Biosciences Inc Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$2.85 - $4.19 $74,100 - $108,940	-26,000 Reduced 68.78%	11,800 $45,000
Q3 2023 Nov 14, 2023	BUY	$2.97 - $3.87 $34,452 - $44,892	11,600 Added 44.27%	37,800 $123,000
Q2 2023 Aug 11, 2023	BUY	$3.0 - $5.97 $78,600 - $156,414	26,200 New	26,200 $83,000
Q4 2022 Feb 14, 2023	BUY	$3.78 - $5.81 $71,064 - $109,227	18,800 New	18,800 $79,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $22,185 - $35,670	-8,700 Reduced 36.1%	15,400 $47,000
Q1 2022 May 16, 2022	BUY	$2.5 - $3.42 $19,500 - $26,676	7,800 Added 47.85%	24,100 $66,000
Q4 2021 Feb 14, 2022	BUY	$2.88 - $5.5 $9,216 - $17,600	3,200 Added 24.43%	16,300 $48,000
Q3 2021 Nov 15, 2021	BUY	$3.57 - $5.6 $2,856 - $4,480	800 Added 6.5%	13,100 $62,000
Q2 2021 Aug 11, 2021	BUY	$3.46 - $4.92 $42,558 - $60,516	12,300 New	12,300 $48,000

5.5M

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $97.8M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.